<html>

<head>

<title>Jain Foundation Inc | Conference 2007</title>

<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">

<link rel="stylesheet" href="style.css" type="text/css" />

<style type="text/css">

<!--

.style4 {font-size: 11px}

.style6 {

	font-size: 24px;

	font-weight: bold;

	color: #3D7610;

}

.style7 {

	font-size: 14px;

	color: #3D7610;

	font-weight: bold;

}

.style10 {

	font-size: 12px;

	font-weight: bold;

}

.style11 {font-size: 24px}

.style12 {font-size: 18px}

.style17 {font-size: 17px}

-->

</style>

</head>



<body leftmargin="0" topmargin="10" marginwidth="0" marginheight="10">

<table width="100%" height="100%" border="0" cellspacing="0" cellpadding="0">

  <tr>

    <td align="center">

	

	<table width="780" border="0" cellspacing="0" cellpadding="0">

      <tr>

        <td height="4" background="images/bg_green.gif"></td>

      </tr>

    </table>

	

	<table width="780" height="36" border="0" cellspacing="0" cellpadding="0">

      <tr><? include 'includes/topbar.php'; ?></tr>

    </table>

	

    <table width="780" border="0" cellspacing="0" cellpadding="0">

      <tr height="97">

        <td><a href="index.php"><img src="images/logo_jain.gif" width="260" height="97" border="0"></a></td>

        <td><img src="images/logo_jain2.gif" width="520" height="97"></td>

      </tr>

    </table>



    <table width="780" border="0" cellspacing="0" cellpadding="0">

      <tr>

        <td background="images/bg_dot.gif" width="1"></td>

        <td><table width="778" border="0" cellpadding="0" cellspacing="0" bgcolor="#FFFFFF">

          <tr>

            <td width="187" bgcolor="#FDFFC6" height="13"></td>

            <td></td>

          </tr>

          <tr>

            <td bgcolor="#FDFFC6" align="center" valign="top"><table width="168" border="0" cellspacing="0" cellpadding="0">

                <tr>

                  <td height="4" bgcolor="#E19012"></td>

                </tr>

                <tr>

                  <td><a href="projects.php" onMouseOver="window.document.sq4.src='images/button_ourFunded_roll.gif'" 

onMouseOut="window.document.sq4.src='images/button_ourFunded.gif'"><img src="images/button_ourFunded.gif" border="0" name="sq4" alt="Our Funded Projects" width="168" height="32"></a></td>

                </tr>

				<tr>

                  <td height="1" background="images/bg_dot2.gif"></td>

                </tr>

				<tr>

                  <td><a href="conferences.php" onMouseOver="window.document.sq15.src='images/button_conferences_roll.gif'" 

onMouseOut="window.document.sq15.src='images/button_conferences.gif'"><img src="images/button_conferences.gif" border="0" name="sq15" alt="Sponsored Conferences" width="168" height="32"></a></td>

                </tr>

                <tr>

                  <td height="1" background="images/bg_dot2.gif"></td>

                </tr>

                <tr>

                  <td><a href="apply.php" onMouseOver="window.document.sq5.src='images/button_apply_roll.gif'" 

onMouseOut="window.document.sq5.src='images/button_apply.gif'"><img src="images/button_apply.gif" alt="Apply for Funding" name="sq5" width="168" height="32" border="0" id="sq5"></a></td>

                </tr>

                <tr>

                  <td height="1" background="images/bg_dot2.gif"></td>

                </tr>

                <tr>

                  <td><a href="papers.php" onMouseOver="window.document.sq6.src='images/button_papers_roll.gif'" 

onMouseOut="window.document.sq6.src='images/button_papers.gif'"><img src="images/button_papers.gif" border="0" name="sq6" alt="Relevant Scientific Papers" width="168" height="32"></a></td>

                </tr>

                <tr>

                  <td height="1" background="images/bg_dot2.gif"></td>

                </tr>

                <tr>

                  <td><a href="patients.php" onMouseOver="window.document.sq7.src='images/button_patient_roll.gif'" 

onMouseOut="window.document.sq7.src='images/button_patient.gif'"><img src="images/button_patient.gif" border="0" name="sq7" alt="Patient Registration" width="168" height="32"></a></td>

                </tr>

                <tr>

                  <td height="1" background="images/bg_dot2.gif"></td>

                </tr>

                <tr>

                  <td><a href="faq.php" onMouseOver="window.document.sq8.src='images/button_faq_roll.gif'" 

onMouseOut="window.document.sq8.src='images/button_faq.gif'"><img src="images/button_faq.gif" border="0" name="sq8" alt="FAQ on LGMD2B/Miyoshi" width="168" height="32"></a></td>

                </tr>

				<tr>

                  <td height="1" background="images/bg_dot2.gif"></td>

                </tr>

                <tr>

                  <td><a href="links.php" onMouseOver="window.document.sq16.src='images/button_links2_roll.gif'" 

onMouseOut="window.document.sq16.src='images/button_links2.gif'"><img src="images/button_links2.gif" border="0" name="sq16" alt="Helpful Links" width="168" height="32"></a></td>

                </tr>

                <tr>

                  <td height="4" bgcolor="#E19012"></td>

                </tr>

              </table>

                <? include 'includes/search.php'; ?>

                <table width="168" border="0" cellspacing="0" cellpadding="0">

                  <tr>

                    <td><img src="images/header_researchers.gif" width="168" height="26"></td>

                  </tr>

                  <tr>

                    <td background="images/box_bgMain.gif" valign="top"><p class="left">

                        <? include 'includes/resources.php'; ?>

                        <br>

                        <br>

                         </p>

                    </td>

                  </tr>

                  <tr>

                    <td><img src="images/box_bottom.gif" width="168" height="10"></td>

                  </tr>

                </table>

            </td>

            <td background="images/background.jpg" valign="top" align="center"><table width="92%" border="0" cellspacing="0" cellpadding="0">

              <tr>

                <td valign="top" height="13"></td>

              </tr>

              <tr>

                <td><p align="center" class="home style4"><span class="home"><br>

<br>

                </span><span class="style6">Second Annual Dysferlin Conference</span><span class="home style11"><br>

                </span><span class="style7"><br><br>

                <span class="style12">June 14 - June 18, 2008</span><br>

                </span><br>

<span class="home"></span><br>

<span class="style7">Sponsored by the Jain Foundation Inc.</span><br>

<span class="home"></span><br>

<span class="home"></span><br><br>

                      <br>

                  </p>

                  </td>

              </tr>

              <tr>

                <td><div align="left" class="home style4"><a href="2008summary.php"><img src="images/button_gen_sum.gif" width="79" height="40" border="0"></a> &nbsp;&nbsp;<a href="2008sci_summary.php"><img src="images/button_sci_sum.gif" width="79" height="40" border="0"></a> &nbsp;&nbsp;<a href="2008abstracts.php"><img src="images/button_speak_abs.gif" width="79" height="40" border="0"></a> &nbsp;&nbsp;<a href="2008posters.php"><img src="images/button_post_abs.gif" width="79" height="40" border="0"></a> &nbsp;&nbsp;<a href="2008BOsession.php"><img src="images/button_breakoutsessions.gif" width="79" height="40" border="0"></a><a href="2008program.php"></a> &nbsp;&nbsp;<a href="shows/dysferlinconference2007.html" target="_blank"><img src="images/button_show.gif" width="79" height="40" border="0"></a><br>

<span class="home"></span><br><br>

				<p><span class="style10">Session II: Dysferlinopathy and the Immune System </span><br>

				  <br>

				  <br>

                  <strong><span class="style17">Eric P. Hoffman, PhD</span></strong><br>

                  <em>Children’s National Medical Center
ehoffman@cnmcresearch.org</em><br>
<br>

                  <img src="images/conference2008/Hoffman.jpg" width="135"><br><br>
                  <strong>Dysferlin-Deficiency Shows Compensatory  Induction of Rab27A/Slp2a Alternative Vesicle Trafficking Pathway, Macrophage  Hyper-Activation, and Inflammasome Formation that Drives the Inflammatory Onset  Seen in Many Patients</strong><strong>&nbsp; &nbsp;</strong><br>
Rashmi Rawat1, Akanchha Kesari1, Dwight Francia1, Susan Sparks1, Tatiana Cohen1, Kanneboyina Nagaraju1, Mitsunori Fukuda2, Susan Knoblach1, Rumaisa Bashir3, and Eric P Hoffman1.
1Research Center for Genetic Medicine, Children's National Medical Center, Washington DC,  2Dept. of Developmental Biology and Neurosciences, Tohoku University, Miyagi, Japan,  3 School of Biological and Biochemical Sciences, Univ. of Durham, Durham, UK
</p>
				<p>				 Mutations in the dysferlin gene cause Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Miyoshi Myopathy (MM).  Dysferlin-deficient cells show abnormalities in vesicle traffic and membrane repair, although onset of symptoms is not until late teens, often associated with sub-acute onset and marked muscle inflammation.  To identify molecular networks specific to dysferlin-deficient muscle that might explain disease pathogenesis, muscle mRNA profiles from 10 mutation-positive LGMD2B patients were compared to a disease control (LGMD2I [FKRP]; n=9), and normal muscle samples (n=11).  Query of inflammatory pathways suggested LGMD2B-specific increase in co-stimulatory signaling between dendritic cells and T cells (CD86, CD28, CTLA4), associated with localized expression of versican and tenascin.  LGMD2B muscle also showed an increase in vesicle trafficking pathway proteins not normally observed in muscle (Synaptotagmin-like protein SYTL2 and small GTPase Rab27A). We propose that Rab27A/Slp2a expression in LGMD2B muscle provides a compensatory vesicle trafficking pathway, able to repair membrane damage in the absence of dysferlin.  However, this same compensatory pathway may release endocytotic vesicle contents, resulting in an inflammatory microenvironment.  
To further investigate the inflammatory aspects of dysferlin deficient human and mouse muscle tissues, we show that components of inflammasome pathway (e.g., P2X7 receptors, ASC-1, NALP, caspase-1, and IL-1 beta) are differentially upregulated and activated in dysferlin deficient but not normal mouse and human skeletal muscle.  We then showed that normal primary skeletal muscle cells are capable of secreting IL-1 beta in response to LPS and P2X7 receptor agonist, benzylated ATP. We have further found that inflammasome pathway adaptor proteins (e.g., ASC-1, Caspase -1) as well IL-1 beta are highly activated in dysferlin deficient compared to normal primary mouse muscle cells in response to LPS and benzylated ATP.  These data clearly demonstrate that inflammasome pathway is not only highly activated in dysferlin deficiency but also for the first time demonstrate that skeletal muscle is an active contributor of IL-1 beta and may be involved in initiation and progression of inflammatory response in this disease.  Strategies that interfere with this pathway may be therapeutically useful for LGMD2B patients.  
In conclusion, our assembled human and mouse data suggests that dysferlin-deficiency enhances phagocytosis by macrophages (Nagaraju et al. 2008), and this coupled with our findings of abnormal myofiber endocytosis pathways and dendritic-T cell activation markers suggests a model of over-stimulation of T cell – dendritic cell networks.  These networks inappropriately and aggressively activate the inflammasome pathway, and this in turn drives the sub-acute inflammatory presentation in many patients.
 </p>
<p><a name="2"></a><br>
  
  
  <strong><span class="style17">Simone Spuler, Prof. MD</span></strong><br>
  
  <em>Muscle Research Unit, Charité University Medicine Berlin, Experimental and Clinical Research Center
    simone.spuler@charite.de </em><br>
    <br>
  
    <img src="images/conference2008/Spuler.jpg" width="135"><br><br>
  
    <strong>Complement Inhibitory Factor CD55 is Downregulated on Dysferlin-Deficient Muscle Fibers</strong><strong>&nbsp; &nbsp;</strong><br>
    <br>
  
  We compared intra-individual mRNA expression profiles of skeletal muscle in dysferlin-deficient SJL/J and C57BL/6 mice and found downregulation of the complement inhibitor decay accelerating factor (DAF/CD55) in dysferlin-deficient skeletal muscle.  This finding was confirmed at the mRNA and protein levels, in two additional dysferlin-deficient mouse strains, A/J mice and Dysf-/- mice, as well as in patients with dysferlin-deficient muscular dystrophy.  The muscle fibers are decorated with C5b9 membrane attack complex.  In vitro, the absence of CD55 led to an increased susceptibility of human myotubes to complement attack. 
  We hypothesize that inhibition of the complement system or upregulation of CD55 are therapeutic strategies in dysferlin deficiency that will slow down the disease course.  We tested this hypothesis by several means:  1. Intravenous immunoglobulins (IVIG) in 3 LGMD2B patients because of the complement inhibitory properties of IVIG.  2. Anti-C5 antibody treatment in SJL/J mice.  3. Comparison of complement factor C5 levels in different dysferlin-deficient mouse strains.</p>

<p><br>

				  <a name="3"></a>

                  <strong><span class="style17">Christina Jamieson, PhD</span></strong><br>

                  <em>University of California, Los Angeles School of Medicine
cjamieson@mednet.ucla.edu</em><br><br>

                  <img src="images/conference2008/Jamieson.jpg" width="135"><br><br>

                  <strong>Dysferlin Regulation and Function in T Cell Death and Survival</strong><strong>&nbsp; &nbsp;</strong><br>

<br>

Background:  Inflammation and progressive loss of muscle occur in patients with Limb Girdle Muscular Dystrophy 2B and Myoshi Myopathy (LGMD2B/MM) due to loss-of-function mutations in the dysferlin gene.  Although glucocorticoids suppress inflammation and decrease disease progression in most muscular dystrophies and muscle inflammatory diseases, they are ineffective and sometimes exacerbate muscle damage in LGMD2B/MM patients.  We used global gene expression profiling in time series experiments to investigate the effects of glucocorticoid treatment of T cells on dysferlin expression.  
Methods and Results:  Genome-wide DNA microarrays revealed that dexamethasone (Dex), a synthetic glucocorticoid, induced dysferlin expression in the 2B4.11 T cell line in time course experiments (0, 0.5h, 1h, then every 2 hours up to 16 hours of Dex, n=2). Dysferlin was not induced in cells treated with Dex plus anti-CD3 antibody which inhibited apoptosis.  Synaptotagmins-1, -3 and XVb were induced with a gene expression signature similar to dysferlin.  Gene expression changes were verified using quantitative RT-PCR.  Whole body gamma-irradiation (10 Gy) of mice, which activates apoptosis in T cells, induced dysferlin in thymus and in quadriceps muscle within 1-3 hours.  Treatment of C2C12 cells with Dex in myoblast differentiation time course experiments resulted in increased and accelerated myotube formation.  Notably, Western blot analysis demonstrated that this treatment also increased dysferlin protein levels. 
Conclusions:  Our data suggest that dysferlin is inducible in T cells and in muscles in response to at least two cell stressors.  We are investigating this novel regulation and function of dysferlin in T cell apoptosis.  We propose that a critical therapeutic benefit of glucocorticoids may be the induction of dysferlin and up-regulation of muscle membrane repair.  In dysferlinopathy this component is missing, and therefore, may explain, at least in part, the ineffectiveness of glucocorticoids in this disease.  Understanding the mechanisms that regulate dysferlin during muscle repair and inflammation mediated by T cells may lead to therapies that both augment dysferlin function and reduce muscle inflammation in dysferlinopathy patients. </p>

<p><br>

                    <strong><span class="style17"><br>

                    </span></strong></p>

                </div></td>

              </tr>

            </table></td>

          </tr>

          <tr>

            <td bgcolor="#FDFFC6" align="center" valign="top">&nbsp;</td>

            <td bgcolor="ffffff">&nbsp;</td>

          </tr>

          <tr>

            <td height="30" align="right" bgcolor="#FDFFC6"></td>

            <td height="30" align="right" valign="middle" bgcolor="#FDFFC6"><p class="footer">

                <? include 'includes/footer.php'; ?>

              </p>

            </td>

          </tr>

        </table></td>

        <td background="../../images/bg_dot.gif" width="1"></td>

      </tr>

    </table>

    <table width="780" border="0" cellspacing="0" cellpadding="0">

      <tr>

        <td height="4" background="../../images/bg_green.gif"></td>

      </tr>

    </table>

	

	</td>

  </tr>

</table>

</body>

</html>

